Maayan, Rachel

Increased circulatory dehydroepiandrosterone and dehydroepiandrosterone-sulphate in first-episode schizophrenia: relationship to gender, aggression and symptomatology

Strous, R. D., Maayan, R., Lapidus, R., Goredetsky, L., Zeldich, E., Kotler, M., & Weizman, A. (2004) · Schizophrenia Research

Schizophrenia research and treatmentStress Responses and Cortisol

Cited by 92

Pregnenolone and Dehydroepiandrosterone as an Adjunctive Treatment in Schizophrenia and Schizoaffective Disorder: An 8-Week, Double-Blind, Randomized, Controlled, 2-Center, Parallel-Group Trial

Ritsner, M. S., Gibel, A., Shleifer, T., Boguslavsky, I., Zayed, A., Maayan, R., Weizman, A., & Lerner, V. (2010) · The Journal of Clinical Psychiatry

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 85

Lowered DHEA-S plasma levels in adult individuals with autistic disorder

Strous, R. D., Golubchik, P., Maayan, R., Mozes, T., Tuati-Werner, D., Weizman, A., & Spivak, B. (2005) · European Neuropsychopharmacology

Autism Spectrum Disorder ResearchSexual Differentiation and Disorders

Cited by 59

Serum levels of brain-derived neurotrophic factor and cortisol to sulfate of dehydroepiandrosterone molar ratio associated with clinical response to L-theanine as augmentation of antipsychotic therapy in schizophrenia and schizoaffective disorder patients

Miodownik, C., Maayan, R., Ratner, Y., Lerner, V., Pintov, L., Mar, M., Weizman, A., & Ritsner, M. S. (2011) · Clinical Neuropharmacology

Schizophrenia research and treatmentTryptophan and brain disorders

Cited by 31

Circulatory neurosteroid levels in smoking and non-smoking chronic schizophrenia patients

Iancu, I., Tchernihovsky, E., Maayan, R., Poreh, A., Dannon, P., Kotler, M., Weizman, A., & Strous, R. D. (2007) · European Neuropsychopharmacology

Schizophrenia research and treatmentSmoking Behavior and Cessation

Cited by 14